APA (7th ed.) Citation

Daghriri, S., Alorfi, Y. A., Alayed, R. S., Altaf, W. F., Alharbi, G. E., Alsulami, H., . . . Softah, A. (2025). The efficacy and safety of Nusinersen for spinal muscular atrophy types 1, 2, 3: A systematic review of the current evidence. Egyptian Journal of Neurology, Psychiatry & Neurosurgery, 61(1), 1. https://doi.org/10.1186/s41983-025-00959-4

Chicago Style (17th ed.) Citation

Daghriri, Somaia, Yara A. Alorfi, Rasil Sulaiman Alayed, Wid F. Altaf, Ghaida E. Alharbi, Hisham Alsulami, Raghad Alkhalifah, Omar Alzahrani, and Abdulrahman Softah. "The Efficacy and Safety of Nusinersen for Spinal Muscular Atrophy Types 1, 2, 3: A Systematic Review of the Current Evidence." Egyptian Journal of Neurology, Psychiatry & Neurosurgery 61, no. 1 (2025): 1. https://doi.org/10.1186/s41983-025-00959-4.

MLA (9th ed.) Citation

Daghriri, Somaia, et al. "The Efficacy and Safety of Nusinersen for Spinal Muscular Atrophy Types 1, 2, 3: A Systematic Review of the Current Evidence." Egyptian Journal of Neurology, Psychiatry & Neurosurgery, vol. 61, no. 1, 2025, p. 1, https://doi.org/10.1186/s41983-025-00959-4.